Navigation Links
Certain form of tomatoes could be key to prostate cancer prevention
Date:5/29/2008

COLUMBIA, Mo. New cancer research from the University of Missouri suggests that eating a certain form of tomato product could be the key to unlocking the prostate cancer-fighting potential of the tomato. The positive effect of tomato products has been suggested in many studies, but, until now, researchers did not know exactly what caused this effect.

It appears that the greatest protective effect from tomatoes comes from rehydrating tomato powder into tomato paste, said Valeri Mossine, research assistant professor of biochemistry in the College of Agriculture, Food and Natural Resources. Processing of many edible plants through heating, grinding, mixing or drying dramatically increases their nutritional value and cancer-fighting potential.

Mossine and his colleagues found that FruHis an organic carbohydrate present in dehydrated tomato products exerts a strong protective effect against prostate cancer. Rats, injected with prostate cancer-causing chemicals, were divided into groups and fed different diets. The group fed a diet of tomato paste plus additional FruHis demonstrated the longest survival rate. Only 10 percent in that group had developed prostate tumors. Sixty percent in the control group had tumors; 30 percent of the group fed tomato powder had tumors; and 25 percent of the group fed tomato paste alone had prostate tumors.

Before this study, researchers attributed the protective effect of tomatoes to ascorbic acid, carotenoids or phenolic compounds. FruHis may represent a novel type of potential dietary antioxidant, Mossine said. Our ongoing research now focuses on unraveling the mechanisms behind why this has a beneficial effect. This knowledge may lead to other avenues of research and drug development for prostate and other cancers. Results of this study certainly warrant clinical trials.


'/>"/>

Contact: Jennifer Faddis
faddisj@missouri.edu
573-882-6217
University of Missouri-Columbia
Source:Eurekalert

Page: 1

Related biology news :

1. Uncertainty drives the evolution of cooperative breeding in birds
2. Bilberry extract -- can it help prevent certain cancers?
3. Certain diseases, birth defects may be linked to failure of protein recycling system
4. Managing uncertainty important in ecological balance: ASU researcher
5. Can certain metals repel sharks from fishing gear?
6. Presence of certain antibodies signals healthier teeth and gums
7. Newly created cancer stem cells could aid breast cancer research
8. Obesity and lack of exercise could enhance the risk of pancreatic cancer
9. Finding that 1-in-a-billion that could lead to disease
10. 60 second test could help early diagnosis of common brain diseases
11. Auto immune response creates barrier to fertility; could be a step in speciation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2015)... Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces that its leading payment ... media at Digital Experience! @ NYC June 18th. ... the latest innovation in technology to over 300 of the ... at the Metropolitan Pavilion in New York City ...
(Date:6/10/2015)... June 10, 2015 According ... Market by Technology (Ultrasound, TOF, Structured Light, Stereo ... Entertainment, Automotive) and by Geography - Trends & ... the market is expected to reach $3,319.71 Million ... between 2015 and 2020. Browse 71 ...
(Date:6/8/2015)... Inc. (NASDAQ: TROV ), a developer of cell-free molecular ... Monitoring SM platform will be presented at the ... San Diego, CA on June 11-12 , and ... and Cancer Therapy in Salt Lake City, ... continue to advance our clinical programs and present data to ...
Breaking Biology News(10 mins):Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 33D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
... very good at what they do. But they don,t ... work in oily or dangerous environments, or in any kind ... of the fastest and most maneuverable creatures on the planet, ... to their streamlined bodies and a finely tuned muscular/sensory/control system. ...
... Rochelle, NY, September 19, 2012 Many biotech observers ... be based on the field of personalized medicine, ... ( GEN ) ( http://genengnews.com ). Although drug ... of biosamples, demand is exceeding supply, fueling the ...
... researchers at Michigan State University has documented the step-by-step process ... in the current issue of Nature , are revealed ... coli bacteria figured out how to supplement a traditional ... "It,s pretty nifty to see a new biological function evolve," ...
Cached Biology News:Robotic tuna is built by Homeland Security 2Evolution is as complicated as 1-2-3 2
(Date:6/30/2015)... /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today ... have approved the resolutions relating to: (i) a ... units at a price of $2.67 per unit ... of one common share and 0.075358 common share ... million; and (ii) the amendment to Resverlogix,s articles ...
(Date:6/30/2015)... NEW YORK , June 30, 2015  Today, Americord ... the U.S., announced Andrew Horne , a partner at ... Advisory Board. Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   ... appointment to Americord,s Advisory Board," says Martin Smithmyer , ... experience in his legal career that will assist Americord,s growth ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... The maximum ... of Cryo-Cell’s currently outstanding common shares (including shares of unvested restricted stock). On June ... the last sale price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per ...
(Date:6/30/2015)... 30, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... its Phase 1/2 clinical trial of RCT-01, being ... tendinosis, has been enrolled and their tissue biopsy ... RCT-01 is comprised of non-bulbar dermal sheath (NBDS) ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
... Medarex, Inc.,(Nasdaq: MEDX ) announced today that it ... Emerging Growth Conference in New York City on Tuesday,September ... will be,webcast live and will be available for replay ... the Medarex website via the Internet at, http://www.medarex.com ...
... Leading scientists,from around the world will meet in ... producing life-saving vaccines and,antibodies. More than 125 scientists ... for New Vaccines II: Focus on Respiratory Virus,Diseases" ... The international,scientific workshop is being organized by the ...
... (Amex: PTN ) stated today that the ... Technologies, Inc. (Amex: CTT ),relating to a ... was,false and misleading. The press release issued ... with Palatin Technologies." However, the,Notice of Termination sent ...
Cached Biology Technology:International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development 2Palatin Technologies Refutes Competitive Technologies Contention of Material Breach 2
Mouse monoclonal antibody raised against a partial recombinant ACTN4. NCBI Entrez Gene ID = ACTN4...
Rabbit polyclonal antibody to GluR2...
... can be used to test the crossreactivity ... sera that are commonly used as blocking ... spots for 19 different protein preparations on ... crossreactivity and species specificity, QC of purified ...
... array sample elements. , ,Includes: , DiscoverLight ... BSA in PBS (10X): 50 ml , ... , BupH Phosphate Buffered Saline: 8 packs ... ml ampules , SuperSignal West Pico Luminol Enhancer: 2 ...
Biology Products: